To view or add a comment, sign in I appreciated the opportunity to be interviewed by Nick Paul Taylor for this BioSpace article discussing the FDAs recently published draft guidance, General Considerations for the Use of New Approach Methodologies in Drug Development. Historically, drug developers have often included in vitro NAM assay reports in regulatory submissions with limited explanatory context, resulting in minimal impact on the regulators safety assessment
Pending legislation Medications like Wegovy and Zepbound arent typically covered by Medicaid, but coverage may change in the future
But I want to know from your perspective and all the research youve done around diet and dietary guidelines, what do you tell patients and what do you recommend that doctors tell their patients
Minimizing side effects through lower doses can improve tolerability and adherence to treatment plans
Maintain regular sleep: Poor sleep causes fatigue and makes nausea harder to manage
If youre considering GLP-1 therapy, RXIV Infusions offers expert support, personalized dosing, and professional care to help you reach your health goals